Doctor profile · Federal record

Dr. Stavroula Otis, M.D.

Hematology & Oncology Physician (CMS: Hematology) · Orange, CA

  • NPI 1477677557
  • Accepts Medicare
  • MIPS 95.3 / 100 · 2023
  • 23 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
363 S Main St Ste 485
Orange, CA 928683833
(714) 835-4800
Additional location
1401 N Tustin Ave Ste 220
Santa Ana, CA 927058689
fax (714) 835-1900

Credentials & registration

NPPES · NUCC
NPI registered
March 2007 — 19 yrs on file
Profile last updated
January 23, 2024
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A100358

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1477677557. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
121,898
Distinct HCPCS
10
Medicare allowed
$1,187,783
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 72,750 44 $1
J0897 Injection, denosumab, 1 mg 25,560 91 $23
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 6,081 16 $8
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 5,421 22 $8
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,518 29 $0
J1626 Injection, granisetron hydrochloride, 100 mcg 1,456 25 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 1,447 483 $139
36415 Insertion of needle into vein for collection of blood sample 1,376 342 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,366 305 $8
96372 Injection of drug or substance under skin or into muscle 747 139 $16

In context: peer comparison

Among 20 peers in Orange Hematology & Oncology Physician, average services per provider: 1,067. This provider delivers 114× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,529
Transactions
91
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Daiichi Sankyo INC. 8 $271.88
Novartis Pharmaceuticals Corporation 10 $258.25
Gilead Sciences, INC. 11 $215.09
Janssen Biotech, INC. 11 $200.66
Celgene Corporation 13 $194.10
BeiGene USA, INC. 4 $126.68
Takeda Pharmaceuticals U.S.A., INC. 4 $99.87
Merck Sharp & Dohme LLC 4 $96.89
E.R. Squibb & Sons, L.L.C. 5 $88.42
Pfizer INC. 6 $85.10
Incyte Corporation 3 $77.13
Abbvie INC. 3 $57.94
Array Biopharma INC 5 $52.13
Rigel Pharmaceuticals, INC. 2 $42.56
Genentech USA, INC. 2 $41.55

By nature of payment

Food and Beverage
$2,407
Education
$122

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
463
Patients
118
Total drug cost
$207,432
Drug Type Claims Patients Total cost
Anastrozole Generic 151 41 $3,628
Eliquis (Apixaban) Brand 63 12 $38,868
Bicalutamide Generic 31 12 $677
Letrozole Generic 29 13 $1,873
Prochlorperazine Maleate Generic 26 15 $780
Sodium Chloride (0.9 % Sodium Chloride) Brand 23 0 $685
Tamoxifen Citrate Generic 22 0 $1,132
Lorazepam Generic 20 14 $97
Acyclovir Generic 17 0 $132
Hydroxyurea Generic 16 0 $319

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Stavroula Otis's medical specialty?
Dr. Stavroula Otis practices Hematology & Oncology Physician in Orange, CA.
Where does Dr. Stavroula Otis practice?
Dr. Stavroula Otis practices at 363 S Main St Ste 485, Orange, CA 928683833. Office phone: 7148354800.
What is Dr. Stavroula Otis's NPI?
Dr. Stavroula Otis's National Provider Identifier (NPI) is 1477677557, issued by NPPES.
Does Dr. Stavroula Otis accept Medicare assignment?
Yes. Dr. Stavroula Otis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stavroula Otis commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, denosumab, 1 mg (HCPCS J0897); Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS Q5106). Source: CMS Medicare Physician & Other Practitioners file.